Binnopharm Group reported for 2023 by IFRS

Binnopharm Group, part of Sistema, IFRS net profit for 2023 amounted to ₽0.307 billion, down 5 times from ₽1.52 billion in the previous year. Revenue increased 16% to ₽32.54 billion against ₽28.04 billion a year earlier.